Sekisui XenoTech's strong reputation for high quality in vitro drug metabolism studies attracted the attention of Sekisui, who became our parent company in August, 2008. This alignment has allowed us to offer a much wider range of services to accelerate drug development, including the areas of in vivo ADME, Drug Metabolism, Transporters and Drug-Drug Interactions.
As a premier provider of in vitro drug metabolism and drug-drug interaction studies to pharmaceutical companies worldwide, we have unparalleled experience in evaluating drug candidates as substrates, inhibitors and inducers of drug-metabolizing enzymes. Core capabilities include Enzyme Inhibition, Enzyme Induction, Drug Metabolism, Drug Transport and Analytical Services